Prediction of risk factors and electrocardiographic changes in chronic kidney disease patients

Sanjaya Kumar Panigrahi1, Madhuchhanda Pattnaik2, Aruna Acharya3

  • 1Department of Physiology, 627109MKCG Medical College and Hospital, Berhampur, Ganjam, 760004, India.

Insights

This study develops accurate predictive models for cardiovascular events in chronic kidney disease (CKD) patients using biosensor data and machine learning. Early identification of risks aids in preventing CKD progression and complications.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomedical Engineering

Background:

  • Chronic kidney disease (CKD) presents a significant global health challenge, increasing morbidity and mortality, especially from cardiovascular events.
  • Effective management of CKD necessitates early identification and intervention for risk factors to prevent disease progression and associated complications.
  • The heterogeneity of CKD across diverse populations complicates the development of generalized predictive strategies.

Purpose of the Study:

  • To develop accurate predictive models for cardiovascular events in patients diagnosed with chronic kidney disease.
  • To integrate physiological parameters captured by biosensors with machine learning techniques for enhanced predictive capabilities.
  • To explore the utility of genetic and non-genetic risk scores in conjunction with physiological data for cardiovascular risk assessment in CKD.

Main Methods:

  • Utilized biosensors to capture key physiological parameters: Oxygen saturation (SpO2), Pulse rate (PR), Perfusion index (Pi), Respiration rate (RRp), and Pleth variability index (PVi).
  • Applied Stacked Auto-Encoders (SAEs) for diagnostic analysis of the captured physiological data.
  • Developed Genetic Risk Score (GRS) and Non-Genetic Risk Score (NGRS) models using natural logarithms of odds ratios (OR) for risk factor evaluation.

Main Results:

  • Developed predictive models integrating weighted contributions of various factors to forecast cardiovascular events in CKD patients.
  • A novel machine learning approach incorporating automatic machine learning (AutoML) was implemented to enhance model accuracy.
  • The integrated models demonstrated potential for improved cardiovascular risk prediction in the CKD population.

Conclusions:

  • The developed models effectively integrate physiological properties and risk factors with weighted contributions for predicting cardiovascular events in CKD.
  • The incorporation of automatic machine learning (AutoML) represents a significant advancement in predictive modeling for CKD complications.
  • These findings support the use of advanced machine learning and comprehensive physiological monitoring for proactive cardiovascular risk management in CKD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
728
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
653
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
472
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
392
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
325